BioCentury
ARTICLE | Clinical News

BREVAGen regulatory update

August 13, 2012 7:00 AM UTC

Genetic Technologies received CE Mark approval for its BREVAGen genetic test to determine an individual's risk of developing non-familial breast cancer. The breast cancer stratification test combines ...